Package 68462-494-90

{"route": ["ORAL"], "spl_id": "e2349a09-1e53-462c-b185-225ca0a400a4", "openfda": {"nui": ["N0000000144", "N0000175522", "N0000185506", "N0000187062", "N0000182138"], "unii": ["V8G4MOF2V9"], "rxcui": ["597768", "597770", "597772"], "spl_set_id": ["59f1d3fb-5bdb-4261-8557-9a4bde8b3c1c"], "pharm_class_epc": ["Iron Chelator [EPC]"], "pharm_class_moa": ["Iron Chelating Activity [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FOR SUSPENSION in 1 BOTTLE (68462-494-90)", "package_ndc": "68462-494-90", "marketing_start_date": "20200106"}], "brand_name": "deferasirox", "product_id": "68462-494_e2349a09-1e53-462c-b185-225ca0a400a4", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "68462-494", "generic_name": "deferasirox", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "deferasirox", "active_ingredients": [{"name": "DEFERASIROX", "strength": "125 mg/1"}], "application_number": "ANDA209433", "marketing_category": "ANDA", "marketing_start_date": "20200106", "listing_expiration_date": "20261231"}